cholestyramine resin has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Donia, MB; Lack, L; Rahman, AA; Suliman, HB | 1 |
| Fischbach, W; Flieger, D; Hainke, S; Keller, R; Klassert, C; Kleinschmidt, R | 1 |
1 trial(s) available for cholestyramine resin and Colorectal Cancer
| Article | Year |
|---|---|
Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Camptothecin; Cholestyramine Resin; Colorectal Neoplasms; Diarrhea; Female; Humans; Irinotecan; Levofloxacin; Male; Middle Aged; Ofloxacin; Time Factors | 2007 |
1 other study(ies) available for cholestyramine resin and Colorectal Cancer
| Article | Year |
|---|---|
Cholestyramine feeding lowers number of colonic apoptotic cells in rat.
Topics: Administration, Oral; Animal Feed; Animals; Anion Exchange Resins; Apoptosis; Bile Acids and Salts; Cholestyramine Resin; Colorectal Neoplasms; In Situ Nick-End Labeling; Inflammation; Intestinal Mucosa; Male; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley | 2005 |